AAAAAA

   
Results: 1-23 |
Results: 23

Authors: Rex, JH Walsh, TJ Nettleman, M Anaissie, EJ Bennett, JE Bow, EJ Carillo-Munoz, AJ Chavanet, P Cloud, GA Denning, DW de Pauw, BE Edwards, JE Hiemenz, JW Kauffman, CA Lopez-Berestein, G Martino, P Sobel, JD Stevens, DA Sylvester, R Tollemar, J Viscoli, C Viviani, MA Wu, T
Citation: Jh. Rex et al., Need for alternative trial designs and evaluation strategies for therapeutic studies of invasive mycoses, CLIN INF D, 33(1), 2001, pp. 95-106

Authors: Klijn, JGM Blamey, RW Boccardo, F Tominaga, T Duchateau, L Sylvester, R
Citation: Jgm. Klijn et al., Combined tamoxifen and luteinizing hormone-releasing hormone (LHRH) agonist versus LHRH agonist alone in premenopausal advanced breast cancer: A meta-analysis of four randomized trials, J CL ONCOL, 19(2), 2001, pp. 343-353

Authors: Jakse, G Hall, R Bono, A Holtl, W Carpentier, P Spaander, JP van der Meijden, APM Sylvester, R
Citation: G. Jakse et al., Intravesical BCG in patients with carcinoma in situ of the urinary bladder: Long-term results of EORTC GU group phase II protocol 30861, EUR UROL, 40(2), 2001, pp. 144-150

Authors: Duchateau, L Pignon, JP Bijnens, L Bertin, S Bourhis, J Sylvester, R
Citation: L. Duchateau et al., Individual patient-versus literature-based meta-analysis of survival data:Time to event and event rate at a particular time can make a difference, an example based on head and neck cancer, CONTR CL TR, 22(5), 2001, pp. 538-547

Authors: Mickisch, GHJ Garin, A van Poppel, H de Prijck, L Sylvester, R
Citation: Ghj. Mickisch et al., Radical nephrectomy plus interferon-alfa-based immunotherapy compared withinterferon alfa alone in metastatic renal-cell carcinoma: a randomised trial, LANCET, 358(9286), 2001, pp. 966-970

Authors: van der Meijden, APM Brausi, M Zambon, V Kirkels, W de Balincourt, C Sylvester, R
Citation: Apm. Van Der Meijden et al., Intravesical instillation of epirubicin, bacillus Calmette-Guerin and bacillus Calmette-Guerin plus isoniazid for intermediate and high risk Ta, T1 papillary carcinoma of the bladder: A European organization for research andtreatment of cancer genito-urinary group randomized phase III trial, J UROL, 166(2), 2001, pp. 476-481

Authors: Mack, D Holtl, W Bassi, P Brausi, M Ferrari, P de Balincourt, C Sylvester, R
Citation: D. Mack et al., The ablative effect of quarter dose bacillus Calmette-Guerin on a papillary marker lesion of the bladder, J UROL, 165(2), 2001, pp. 401-403

Authors: Duchateau, L Sylvester, R
Citation: L. Duchateau et R. Sylvester, Meta-analysis, HANDBOOK OF STATISTICS IN CLINICAL ONCOLOGY, 2001, pp. 525-543

Authors: Sylvester, R Collette, L Duchateau, L
Citation: R. Sylvester et al., The role of meta-analyses in assessing cancer treatments, EUR J CANC, 36(11), 2000, pp. 1351-1358

Authors: Sylvester, R Sternberg, C
Citation: R. Sylvester et C. Sternberg, The role of adjuvant combination chemotherapy after cystectomy in locally advanced bladder cancer: What we do not know and why, ANN ONCOL, 11(7), 2000, pp. 851-856

Authors: Paridaens, R Biganzoli, L Bruning, P Klijn, JGM Gamucci, T Houston, S Coleman, R Schachter, J Van Vreckem, A Sylvester, R Awada, A Wildiers, J Piccart, M
Citation: R. Paridaens et al., Paclitaxel versus doxorubicin as first-line single-agent chemotherapy for metastatic breast cancer: A European organization for research and treatment of cancer randomized study with cross-over, J CL ONCOL, 18(4), 2000, pp. 724-733

Authors: Kurth, KH Bouffioux, C Sylvester, R van der Meijden, APM Oosterlinck, W Brausi, M
Citation: Kh. Kurth et al., Treatment of superficial bladder tumors: Achievements and needs, EUR UROL, 37, 2000, pp. 1-9

Authors: Dalesio, O van Tinteren, H Clarke, M Peto, R Schroder, FH Dechering, I Evans, V Godwin, J Blumenstein, BA Crawford, ED Denis, L Hall, R Hill, C Iversen, P Shipley, WU Soloway, M Sylvester, R
Citation: O. Dalesio et al., Maximum androgen blockade in advanced prostate cancer: an overview of the randomised trials, LANCET, 355(9214), 2000, pp. 1491-1498

Authors: Julien, JP Bijker, N Fentiman, IS Peterse, JL Delledonne, V Rouanet, P Avril, A Sylvester, R Mignolet, F Bartelink, H Van Dongen, JA
Citation: Jp. Julien et al., Radiotherapy in breast-conserving treatment for ductal carcinoma in situ: first results of the EORTC randomised phase III trial 10853, LANCET, 355(9203), 2000, pp. 528-533

Authors: Van Der Meijden, A Sylvester, R Collette, L Bono, A Ten Kate, F
Citation: A. Van Der Meijden et al., The role and impact of pathology review on stage and grade assessment of stages Ta and T1 bladder tumors: A combined analysis of 5 European organization for research and treatment of cancer trials, J UROL, 164(5), 2000, pp. 1533-1537

Authors: Duchateau, L Collette, L Sylvester, R Pignon, JP
Citation: L. Duchateau et al., Estimating number of events from the Kaplan-Meier curve for incorporation in a literature-based meta-analysis: What you don't see you can't get!, BIOMETRICS, 56(3), 2000, pp. 886-892

Authors: van Tienhoven, G Voogd, AC Peterse, JL Nielsen, M Andersen, KW Mignolet, F Sylvester, R Fentiman, IS van der Schueren, E van Zijl, K Blichert-Toft, M Bartelink, H van Dongen, JA
Citation: G. Van Tienhoven et al., Prognosis after treatment for loco-regional recurrence after mastectomy orbreast conserving therapy in two randomised trials (EORTC 10801 and DBCG-82TM), EUR J CANC, 35(1), 1999, pp. 32-38

Authors: Blom, JHM van Poppel, H Marechal, JM Jacqmin, D Sylvester, R Schroder, FH de Prijck, L
Citation: Jhm. Blom et al., Radical nephrectomy with and without lymph node dissection: Preliminary results of the EORTC randomized phase III protocol 30881, EUR UROL, 36(6), 1999, pp. 570-575

Authors: Sylvester, R Collette, L
Citation: R. Sylvester et L. Collette, Statistical considerations of chemoprevention clinical trials in prostate cancer, EUR UROL, 35(5-6), 1999, pp. 519-522

Authors: van der Meijden, A Oosterlinck, W Brausi, M Kurth, KH Sylvester, R de Balincourt, C
Citation: A. Van Der Meijden et al., Significance of bladder biopsies in Ta,T1 bladder tumors: A report from the EORTC Genito-Urinary Tract Cancer Cooperative Group, EUR UROL, 35(4), 1999, pp. 267-271

Authors: Sylvester, R
Citation: R. Sylvester, Further reflections, MED PED ONC, 33(4), 1999, pp. 408-408

Authors: Ellis, M Spence, D de Pauw, B Meunier, F Marinus, A Collette, L Sylvester, R Meis, J Boogaerts, M Selleslag, D Kremery, V von Sinner, W MacDonald, P Doyen, C Vandercam, B
Citation: M. Ellis et al., An EORTC international multicenter randomized trial (EORTC number 19923) comparing two dosages of liposomal amphotericin B for treatment of invasive aspergillosis, CLIN INF D, 27(6), 1998, pp. 1406-1412

Authors: Sylvester, R
Citation: R. Sylvester, Establishing a Meta-Analysis Coordination Unit (1994-1996), BIOM HLTH R, 24, 1998, pp. 254-260
Risultati: 1-23 |